SAN DIEGO, March 17, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (“Mirati”) (NASDAQ: MRTX) today reported financial results for the fourth quarter and year ended December 31, 2013 and provided a corporate update.
2013 Corporate Highlights
-- Completed transformational corporate reorganization by recruiting highly experienced precision oncology team, listing company common stock on NASDAQ and establishing corporate headquarters in San Diego, CA
Help employers find you! Check out all the jobs and post your resume.
